Clinical evaluation of two novel biointact PTH(1–84) assays in hemodialysis patients

In chronic kidney disease–mineral and bone disorder (CKD-MBD), most treatment decisions are guided by parathyroid hormone (PTH) levels. Here, we aimed at assessing the technical and clinical performance of two novel automated biointact PTH(1–84) assays, from Roche Diagnostics (Ro) and DiaSorin (DS),...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical biochemistry 2012-12, Vol.45 (18), p.1645-1651
Hauptverfasser:	Hecking, Manfred, Kainz, Alexander, Bielesz, Bernhard, Plischke, Max, Beilhack, Georg, Hörl, Walter H., Sunder-Plassmann, Gere, Bieglmayer, Christian
Format:	Artikel
Sprache:	eng
Schlagworte:	Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Automated biointact Biological and medical sciences Biological Assay - methods Chronic kidney disease-mineral and bone disorder (CKD-MBD) Creatinine - blood Demography Emergency and intensive care: renal failure. Dialysis management Female Hemodialysis patients Humans Intensive care medicine Investigative techniques, diagnostic techniques (general aspects) Kidney Function Tests Kidneys Male Medical sciences Middle Aged Nephrology. Urinary tract diseases Parathyroid hormone (PTH) Parathyroid Hormone - analysis Phosphates - blood PTH(1–84) assays Renal Dialysis Urinary system involvement in other diseases. Miscellaneous
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!